The urea breath test is a non-invasive diagnostic test which uses carbon-14 or carbon-13 labeled urea to detect the presence of H. pylori infection in the stomach. The test is performed by asking the patient to drink a liquid that contains labeled urea. If H. pylori is present in the stomach, it will break down the urea and release labeled carbon dioxide which is breathed out. The breath sample is then analyzed to detect the presence of labeled carbon dioxide, confirming an active H. pylori infection.
The global urea breath test market is estimated to be valued at US$ 140.8 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The growth of the urea breath test market is primarily driven by the increasing prevalence of H. pylori infection across the globe. According to the Centers for Disease Control and Prevention (CDC), nearly two-thirds of the world’s population is infected with H. pylori and around 20-30% of infected individuals may develop diseases like peptic ulcers and gastric cancer. This is increasing the demand for effective diagnostic tests to detect H. pylori infection such as the urea breath test. Additionally, the rising awareness about H. pylori infection and its associated diseases among people is also fueling the adoption of urea breath tests globally. Furthermore, increasing healthcare expenditure in developing countries provides lucrative growth opportunities for players in the urea breath test market.
Segment Analysis
The urea breath test market is segmented into product type and application. Based on product type, the urea breath test kits segment is expected to dominate the market over the forecast period. This is due to growing cases of Helicobacter pylori infection and increasing awareness regarding early diagnosis of gastric ulcers.
PEST Analysis
Political: Government initiatives to spread awareness about gastric infections and provisions of subsidies to low-income patients are boosting the market growth.
Economic: Rising healthcare spending and improving reimbursement policies are fueling the demand for effective diagnosis of Helicobacter pylori infection.
Social: Growing awareness about gut health and risks of gastric ulcers among general population is supporting the adoption of urea breath tests.
Technological: Advancements in kit design improving accuracy and launch of home-use sample collection kits are enhancing the accessibility of urea breath tests.
Key Takeaways
The Global Urea Breath Test Market Size is expected to witness high growth over the forecast period. The global urea breath test market is estimated to be valued at US$ 140.8 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031.
Regionally, North America is expected to dominate the market owing to rising prevalence of gastric ulcers, growing aging population, and availability of advanced healthcare facilities in the region.
Key players operating in the urea breath test market are Al Dahra ACX Global Inc., Alfalfa Monegros SL, Anderson Hay & Grain Inc., Bailey Farms, Border Valley, Coaba, Cubeit Hay Company, Glenvar Hay, Green Prairie International, Grupo Osés, Gruppo Carli, Hay USA, Haykingdom Inc., Oregon Hay Products, Inc., Los Venteros SC, M&C Hay, Legal Alfalfa Products Ltd., Riverina (Australia) Pty Ltd, SL Follen Company, and Standlee Hay Company.
Key players are focusing on new product launches, collaborations, and regulatory approvals to strengthen their market position. For instance, in 2022, Standlee Hay Company launched new alfalfa hay products to cater to the changing demands of cattle producers in the southwest U.S.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
